Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma

Endocrine Journal

Volumn 60, Issue 7, 2013, Pages 903-912

  Akehi, Yuko ^a   Kawate, Hisaya ^b   Murase, Kunitaka ^a   Nagaishi, Ryoko ^a   Nomiyama, Takashi ^a   Nomura, Masatoshi ^b   Takayanagi, Ryoichi ^b   Yanase, Toshihiko ^a,b  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenal incidentaloma; Diagnostic criteria; Subclinical Cushing's syndrome

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PRASTERONE SULFATE;

ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUBCLINICAL CUSHING SYNDROME;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ASYMPTOMATIC DISEASES; CUSHING SYNDROME; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REFERENCE VALUES; YOUNG ADULT;

EID: 84880930518     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0458     Document Type: Article

References (32)

1. Chiodini L (2011) Diagnosis and Treatment of Subclinical Hypercortisolism. J Clin Endocrinol Metab 96: 1223-1236.
2. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, et al. (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87: 4872-4878.
3. Nawata H, Demura H, Suda T, Takayanagi R (1996) Adrenal preclinical Cushing's syndrome, Annual report of the Ministry of Health and Welfare "Disorder of Adrenal Hormones" Research Committee, Japan 1995: 223-226 (In Japanese).
4. Odagiri E, Naruse M, Terasaki K, Yamaguchi N, Jibiki K, et al. (2004) The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J 51: 295-302.
5. Katabami T, Obi R, Shirai N, Naito S, Saito N (2005) Discrepancies in results of low- and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome. Endocr J 52: 463-469.
6. Kawaguchi K, Kuwa K, Takatsu A, Tani W, Kobayashi T (2012) Standarization of cortisol measurement and results of technical examination of low range of cortisol measurement. ACTH RELATED PEPTIDES 22: 2-8 (In Japanese).
7. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, et al. (2008) The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93: 1526-1540.
8. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34 (Pt3): 222-229.
9. Bencsik Z, Szabolcs I, Kovács Z, Ferencz A, Vörös A, et al. (1996) Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. J Clin Endocrinol Metab 81: 1726-1729.
10. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 351(23): 1548-1563.
11. Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, et al. (2010) Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin Endocrinol (Oxf) 73: 161-166.
12. Orth DN (1995) Cushing's syndrome. N Engl J Med 332(22): 791-803.
13. The Japanese Society of Hypertension (2009) Guidelines for the management of hypertension (JSH 2009) (In Japanese).
14. World Health Organization (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, World Health Org.
15. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6): 499-502.
16. Abe M, Araki S, Hyoki M, Sato R, Takamatsu K, et al. (2007) Fundamental evaluation of ACTH measurement using automated electrochemiluminescence-immunoassay system, ECLusys 2010. Igaku to Yakugaku 67: 239-244 (In Japanese).
17. Attached document of ECLusys kit for cortisol (3rd version) (2011) (In Japanese).
18. Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, et al. (2005) Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34: 423-439.
19. Terzolo M, Reimondo G, Bovio S, Angeli A (2004) Subclinical Cushing's syndrome. Pituitary 7: 217-223.
20. Reincke M (2000) Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29: 43-56.
21. Yanase T, Fujieda K, Kajino H, Tanahashi Y, Suzuki S (2011) Epidemiological Investigation of Addison's disease and subclinical Cushing's syndrome in Japan. Annual Report of the Ministry of Health and Welfare "Disorder of Adrenal Hormones" Research Committee, Japan 139-146.
22. Nawata H, Takayanagi R, Nakagawa H, Miura K (1999) Epidemiological Investigation of Disorders of Adrenal Hormones in Japan. Annual Report of the Ministry of Health and Welfare "Disorder of Adrenal Hormones" Research Committee, Japan. 11-55 (In Japanese).
23. Kidambi S, Raff H, Findling JW (2007) Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol 157: 725-731.
24. Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, et al. (2009) The limited role of midnight salivary cortisol in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas. Eur J Endocrinol 160: 87-92.
25. Tateishi Y, Kouyama R, Mihara M, Doi M, Yoshimoto T, et al. (2012) Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome. Endocr J 59(4): 283-289.
26. Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, et al. (2004) Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 60(2): 192-200.
27. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K (2008) Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J 55: 737-745.
28. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V, et al. (2003) Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentalomas: clinical, biochemical and surgical outcomes. Endocr J 50: 399-408.
29. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, et al. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85(4): 1440-1448.
30. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T (2001) The improvement of insulin resistance in patients with adrenal incidentalomas by surgical resection. Clin Endocrinol (Oxf) 54: 797-804.
31. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, et al. (2009) Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249 (3): 388-391.
32. Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, et al. (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95 (6): 2736-2745.